Seaport Therapeutics, Inc.

• Seaport Therapeutics, Inc. - Common Stock (Nasdaq:SPTX) Stock Quote
  FinancialContent · 16 Oct 2026
• Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to
  The National Law Review · 12 Oct 2026
• Seaport Therapeutics Inc (SPTX-Q) Stock Price and News
  The Globe and Mail · 09 Oct 2026
• Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39
  Business Wire · 09 Oct 2026
• Analysts Offer Insights on NA Companies: Quantinuum (QNT) and Seaport Therapeutics, Inc. (SPTX)
  The Globe and Mail · 09 Oct 2026
• PureTech Health's Seaport Therapeutics Unveils Phase 1 Pharmacokinetic Data for GlyphAgo at ECNP 2026
  Kalkine Media · 09 Oct 2026
• Seaport Therapeutics presents GlyphAgo phase 1 data at ECNP By Investing.com
  Investing.com UK · 09 Oct 2026
• H.C. Wainwright reiterates Seaport Therapeutics stock rating on trial start By Investing.com
  Investing.com Canada · 08 Oct 2026
• Seaport Therapeutics doses first patient in anxiety trial By Investing.com
  Investing.com UK · 07 Oct 2026
• Seaport Therapeutics (NASDAQ:SPTX) Shares Gap Up - What's Next?
  MarketBeat · 01 Oct 2026
• Seaport Therapeutics (NASDAQ:SPTX) Now Covered by Raymond James Financial
  MarketBeat · 28 Sep 2026
• Seaport Therapeutics, Inc. $SPTX Shares Newly Acquired by State Street Corp
  MarketBeat · 27 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →